Similar articles

• [Serum gastrin levels in colorectal cancers. Evolution after treatment].

  Seitz JF, Giovannini M, Monges G, Sauvan R, Wartelle C, Martin P. Seitz JF, et al. Gastroenterol Clin Biol. 1992;16(5):385-7. Gastroenterol Clin Biol. 1992. PMID: 1526391 Review. French.
• [Gastrin and colorectal cancer].

  Casella C, Palmieri F, Fontana MG, Ruggeri G, Albertini A, Salerni B. Casella C, et al. Ann Ital Chir. 2001 Jan-Feb;72(1):67-72. Ann Ital Chir. 2001. PMID: 11464499 Italian.
• Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.

  Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G. Oberg A, et al. Anticancer Res. 2000 Mar-Apr;20(2B):1085-91. Anticancer Res. 2000. PMID: 10810401
• Postoperative infections in colorectal cancer patients.

  Horzic M, Kopljar M. Horzic M, et al. Hepatogastroenterology. 2005 Jan-Feb;52(61):101-4. Hepatogastroenterology. 2005. PMID: 15783005
• [Serum gastrin levels, colorectal cancer and tumor resection].

  Martin F. Martin F. Gastroenterol Clin Biol. 1992;16(5):383-4. Gastroenterol Clin Biol. 1992. PMID: 1526390 Review. French. No abstract available.